Search research articles
Contact Us
Filters
Showing results (151-160 of 343) with videos related to
Page
of 35
Sort By:
Cancer
|
March 12, 2015
Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database
Jorge J Castillo, Adam J Olszewski, Zachary R Hunter, et al.
American Journal of Hematology
|
December 9, 2017
Comparing apples to oranges: A commentary on the Mayo study of MYD88 significance in Waldenstrom's macroglobulinemia
Jorge J Castillo, Joshua N Gustine, Kirsten Meid, et al.
British Journal of Haematology
|
October 18, 2016
MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia
Joshua N Gustine, Kirsten Meid, Zachary R Hunter, et al.
The Oncologist
|
January 8, 2011
Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far
Jorge J Castillo, Brady E Beltran, Roberto N Miranda, et al.
Leukemia Research
|
June 6, 2015
Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study
John L Reagan, Matthew R Sullivan, Eric S Winer, et al.
Hematology/Oncology Clinics of North America
|
May 28, 2023
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia
Dipti Talaulikar, Cécile Tomowiak, Elise Toussaint, et al.
American Journal of Hematology
|
April 21, 2016
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management
Jorge J Castillo, Brady E Beltran, Roberto N Miranda, et al.
American Journal of Hematology
|
July 10, 2018
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management
Jorge J Castillo, Brady E Beltran, Roberto N Miranda, et al.
Leukemia & Lymphoma
|
May 1, 2015
The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified
Brady E Beltran, Christian Aguilar, Pilar Quiñones, et al.
American Journal of Hematology
|
April 26, 2022
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management
Luis Malpica, Mario L Marques-Piubelli, Brady E Beltran, et al.
Page
of 35
Search research articles
Search
Showing results (151-160 of 343) with videos related to
Sort By:
Page
of 35
Cancer
|
March 12, 2015
Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database
Jorge J Castillo, Adam J Olszewski, Zachary R Hunter, et al.
American Journal of Hematology
|
December 9, 2017
Comparing apples to oranges: A commentary on the Mayo study of MYD88 significance in Waldenstrom's macroglobulinemia
Jorge J Castillo, Joshua N Gustine, Kirsten Meid, et al.
British Journal of Haematology
|
October 18, 2016
MYD88 mutations can be used to identify malignant pleural effusions in Waldenström macroglobulinaemia
Joshua N Gustine, Kirsten Meid, Zachary R Hunter, et al.
The Oncologist
|
January 8, 2011
Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far
Jorge J Castillo, Brady E Beltran, Roberto N Miranda, et al.
Leukemia Research
|
June 6, 2015
Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study
John L Reagan, Matthew R Sullivan, Eric S Winer, et al.
Hematology/Oncology Clinics of North America
|
May 28, 2023
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia
Dipti Talaulikar, Cécile Tomowiak, Elise Toussaint, et al.
American Journal of Hematology
|
April 21, 2016
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management
Jorge J Castillo, Brady E Beltran, Roberto N Miranda, et al.
American Journal of Hematology
|
July 10, 2018
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management
Jorge J Castillo, Brady E Beltran, Roberto N Miranda, et al.
Leukemia & Lymphoma
|
May 1, 2015
The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified
Brady E Beltran, Christian Aguilar, Pilar Quiñones, et al.
American Journal of Hematology
|
April 26, 2022
EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management
Luis Malpica, Mario L Marques-Piubelli, Brady E Beltran, et al.
Page
of 35